Serum Uric Acid Levels As A Prognostic Indicator in Acute Ischaemic Stroke

Abstract Introduction: Stroke remains a major public health concern worldwide, contributing significantly to morbidity and mortality. Among the different types of strokes, ischemic stroke accounts for the majority of cases, occurring due to the occlusion of cerebral arteries and subsequent ischemic injury. Stroke is the second leading cause of death globally, significantly affecting individuals, families and healthcare systems. Objectives Primary Objective: To study the serum uric acid levels in acute ischemic stroke and assess its prognostic significance. Secondary Objective: To study the association between serum uric acid and various risk factors for stroke. Material and Method: Study Design: Prospective observational study Study Period: 12 months from IEC approval (August 2023 to August 2024) Study Setting: Department of General Medicine, Govt. Medical College, Ernakulam Sample Population: Patients admitted to General medicine wards of Government medical college, Ernakulam with diagnosis of acute ischemic stroke satisfying the inclusion criteria and exclusion criteria. Sampling Method: Consecutive sampling Study Tool: Semi Structured peer reviewed proforma. Result: The study involved 120 participants and the findings revealed that the mean age of stroke patients was 63.25 years, with a male predominance (56.7%). Discussion: Among the study population, hypertension (65%) and dyslipidemia (58.3%) were the most common comorbidities, followed by diabetes (48.3%) and smoking (40.8%). Keywords: Antioxidant, Cyclosporine, Dyslipidemia, Ischemic Stroke, Serum Uric Acid.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-12-30
DOI
https://doi.org/10.5281/zenodo.18976767
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum Uric Acid Levels As A Prognostic Indicator in Acute Ischaemic Stroke

International Journal of Medical Science and Advanced Clinical Research (IJMACR)
Zenodo (CERN European Organization for Nuclear Research)
Gout, Hyperuricemia, Uric Acid
article

Serum Uric Acid Levels As A Prognostic Indicator in Acute Ischaemic Stroke

International Journal of Medical Science and Advanced Clinical Research (IJMACR)
article en

Abstract

Abstract Introduction: Stroke remains a major public health concern worldwide, contributing significantly to morbidity and mortality. Among the different types of strokes, ischemic stroke accounts for the majority of cases, occurring due to the occlusion of cerebral arteries and subsequent ischemic injury. Stroke is the second leading cause of death globally, significantly affecting individuals, families and healthcare systems. Objectives Primary Objective: To study the serum uric acid levels in acute ischemic stroke and assess its prognostic significance. Secondary Objective: To study the association between serum uric acid and various risk factors for stroke. Material and Method: Study Design: Prospective observational study Study Period: 12 months from IEC approval (August 2023 to August 2024) Study Setting: Department of General Medicine, Govt. Medical College, Ernakulam Sample Population: Patients admitted to General medicine wards of Government medical college, Ernakulam with diagnosis of acute ischemic stroke satisfying the inclusion criteria and exclusion criteria. Sampling Method: Consecutive sampling Study Tool: Semi Structured peer reviewed proforma. Result: The study involved 120 participants and the findings revealed that the mean age of stroke patients was 63.25 years, with a male predominance (56.7%). Discussion: Among the study population, hypertension (65%) and dyslipidemia (58.3%) were the most common comorbidities, followed by diabetes (48.3%) and smoking (40.8%). Keywords: Antioxidant, Cyclosporine, Dyslipidemia, Ischemic Stroke, Serum Uric Acid.

Zenodo (CERN European Organization for Nuclear Research)
Advanced Pharma (US)
Openalex Percentile: Top 25%
Gout, Hyperuricemia, Uric Acid
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.